01/06/2017 - 1:21pm

U.S. District Court Judge Sue Robinson on Thursday issued an injunction on the sale of Praluent, a PCSK9 inhibitor from Sanofi and Regeneron. Amgen, maker of another PCSK9 inhibitor Repatha, filed the request for the injunction in 2016.

01/05/2017 - 10:08am

FHC's new chief commercial officer will be responsible for all sales and marketing activities, with the goal of coordinating prelaunch, launch and sales and marketing activities.

01/04/2017 - 2:00pm

Dr. Jay Markowitz will work with other scientific and development leaders to evaluate the company’s portfolio evaluation and decision making while assessing external opportunities. 

01/04/2017 - 1:35pm

The drug, approved by the Food and Drug Administration in November, is indicated to treat adults with Type 2 diabetes that’s inadequately controlled on basal insulin or lixisenatide. 

01/03/2017 - 2:36pm
Forbes is reporting that the Food and Drug Administration’s approval of 22 new drugs in 2016 (down from 51 in 2015) could have big implications for the future of innovation in the pharmaceutical space. The report notes that research spending is growing, but there are practical difficulties to translate innovation into products as R&D returns decline  — and the report suggests overcoming that difficulty could mean rethinking a lot. (Forbes)
12/27/2016 - 1:46pm

Novo Nordisk accused of issuing marketing materials asking patients and doctors to switch from Sanofi’s Lantus and Toujeo drugs to Tresiba, because the Sanofi drugs will be “blocked” by CVS Caremark in January.

12/27/2016 - 11:13am

Spinraza treats SMA, a rare and often fatal genetic disease affecting muscle strength and movement.

12/22/2016 - 9:02am

Dexcom’s G5 Mobile allows for testing for diabetes treatment decisions in people 2 years of age and older with diabetes.

12/21/2016 - 12:45pm

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.